Pharmacotherapy treatment of stimulant use disorder
Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment modality for SUDs and no pharmacotherapy is curr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2021-11-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.347 |
| _version_ | 1827576967890731008 |
|---|---|
| author | Mei T. Liu, PharmD, BCPP |
| author_facet | Mei T. Liu, PharmD, BCPP |
| author_sort | Mei T. Liu, PharmD, BCPP |
| collection | DOAJ |
| description | Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment modality for SUDs and no pharmacotherapy is currently FDA approved for this indication. Although some medications show promising data for the treatment of SUD, the evidence remains inconsistent, and the clinical application is limited due to the heterogenicity of the population and the lack of studies in patients with various comorbidities. Selection of pharmacotherapy treatment for methamphetamine intoxication, persistent methamphetamine-associated psychosis with methamphetamine use disorder, and cocaine use disorder in patients with co-occurring OUD are discussed in 3 patient cases. |
| first_indexed | 2024-03-08T21:20:03Z |
| format | Article |
| id | doaj.art-28887218f01a4132a155f16dd9b638c0 |
| institution | Directory Open Access Journal |
| issn | 2168-9709 |
| language | English |
| last_indexed | 2024-03-08T21:20:03Z |
| publishDate | 2021-11-01 |
| publisher | American Association of Psychiatric Pharmacists |
| record_format | Article |
| series | Mental Health Clinician |
| spelling | doaj.art-28887218f01a4132a155f16dd9b638c02023-12-21T11:44:37ZengAmerican Association of Psychiatric PharmacistsMental Health Clinician2168-97092021-11-0111634735710.9740/mhc.2021.11.347i2168-9709-11-6-347Pharmacotherapy treatment of stimulant use disorderMei T. Liu, PharmD, BCPP0https://orcid.org/0000-0001-8527-93191 Clinical Assistant Professor, Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, Piscataway Township, New Jersey; Clinical Pharmacist ? Psychiatry, Penn Medicine Princeton House Behavioral Health, Princeton, New JerseyStimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the main treatment modality for SUDs and no pharmacotherapy is currently FDA approved for this indication. Although some medications show promising data for the treatment of SUD, the evidence remains inconsistent, and the clinical application is limited due to the heterogenicity of the population and the lack of studies in patients with various comorbidities. Selection of pharmacotherapy treatment for methamphetamine intoxication, persistent methamphetamine-associated psychosis with methamphetamine use disorder, and cocaine use disorder in patients with co-occurring OUD are discussed in 3 patient cases.https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.347methamphetaminecocaineamphetaminestimulant use disorderspharmacotherapy |
| spellingShingle | Mei T. Liu, PharmD, BCPP Pharmacotherapy treatment of stimulant use disorder Mental Health Clinician methamphetamine cocaine amphetamine stimulant use disorders pharmacotherapy |
| title | Pharmacotherapy treatment of stimulant use disorder |
| title_full | Pharmacotherapy treatment of stimulant use disorder |
| title_fullStr | Pharmacotherapy treatment of stimulant use disorder |
| title_full_unstemmed | Pharmacotherapy treatment of stimulant use disorder |
| title_short | Pharmacotherapy treatment of stimulant use disorder |
| title_sort | pharmacotherapy treatment of stimulant use disorder |
| topic | methamphetamine cocaine amphetamine stimulant use disorders pharmacotherapy |
| url | https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.347 |
| work_keys_str_mv | AT meitliupharmdbcpp pharmacotherapytreatmentofstimulantusedisorder |